Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The Prostate

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pros.21138PMID 20503393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

  2009cited by this paper
• Keratinocyte‐derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model

  2009cited by this paper
• Evaluation and treatment of lower urinary tract symptoms in older men.

  2009cited by this paper
• Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

  2008cited by this paper
• Growth factors in benign prostatic hyperplasia: Basic science implications

  2008cited by this paper
• Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.

  2008influential reference
• Holistic Approaches to Prostate Cancer

  2008cited by this paper
• 17β‐Estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins

  2008cited by this paper
• Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo

  2007cited by this paper
• The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries.

  2007cited by this paper
• Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property

  2007cited by this paper
• A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS

  2007cited by this paper
• Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect

  2007cited by this paper
• Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting

  2006cited by this paper
• BPH: epidemiology and comorbidities.

  2006cited by this paper
• Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.

  2006cited by this paper
• Pygeum africanum extract inhibits proliferation of human cultured prostatic fibroblasts and myofibroblasts

  2006cited by this paper
• Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.

  2005cited by this paper
• Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-beta.

  2004cited by this paper
• Mitogen Activated Protein kinase signal transduction pathways in the prostate

  2004cited by this paper
• EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

  2004cited by this paper
• Effect of Pygeum africanum tadenan on micturition and prostate growth of the rat secondary to coadministered treatment and post-treatment with dihydrotestosterone.

  2003cited by this paper
• Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching.

  2003cited by this paper
• [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].

  2003cited by this paper
• Toxicity of chloroform extract of Prunus africana stem bark in rats: gross and histological lesions

  2002cited by this paper
• Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction.

  2002cited by this paper
• Stromal and acinar components of the transition zone in normal and hyperplastic human prostate

  2002cited by this paper
• Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

  2002cited by this paper
• A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens

  2000cited by this paper
• Effects of Pygeum africanum extract (Tadenan®) on vasoactive intestinal peptide receptors, G proteins, and adenylyl cyclase in rat ventral prostate

  2000cited by this paper
• Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.

  2000cited by this paper
• Comparison of marker protein expression in benign prostatic hyperplasia in vivo and in vitro

  2000cited by this paper
• Functional evaluation of Tadenan on micturition and experimental prostate growth induced with exogenous dihydrotestosterone.

  2000cited by this paper
• Determination of the Fatty Acid Content of Pumpkin Seed, Pygeum, and Saw Palmetto

  1999cited by this paper
• Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts.

  1997cited by this paper
• Establishment, maintenance, and cloning of human dermal fibroblasts.

  1997cited by this paper
• [About the prostate].

  1997cited by this paper
• Stromal nodules in benign prostatic hyperplasia.

  1996cited by this paper
• Inhibition of bFGF and EGF-induced proliferation of 3T3 fibroblasts by extract of Pygeum africanum (Tadenan®)

  1994cited by this paper
• Pathology of benign prostatic hyperplasia. Insight into etiology.

  1990cited by this paper
• The development of human benign prostatic hyperplasia with age.

  1984cited by this paper

• The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications.

  2026cites this paper
• Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia

  2025cites this paper
• Taraxacum mongolicum total triterpenoids and taraxasterol ameliorate benign prostatic hyperplasia by inhibiting androgen levels, inflammatory responses, and epithelial-mesenchymal transition via the TGFβ1/Smad signalling pathway.

  2025cites this paper
• Discovery of an enantiopure N-[2-hydroxy-3-phenyl piperazine propyl]-aromatic carboxamide derivative as highly selective α1D/1A-adrenoceptor antagonist and homology modelling

  2024cites this paper
• Autophagy in benign prostatic hyperplasia: insights and therapeutic potential

  2024cites this paper
• Anti-Inflammatory Potential of Pygeum africanum Bark Extract: An In Vitro Study of Cytokine Release by Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells

  2024influential citation
• Deciphering anti-benign prostatic hyperplasia potential of liangwanoside II based on metabolite profile characterization combined with targeted network pharmacology.

  2023cites this paper
• Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review

  2023cites this paper
• Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat

  2023cites this paper
• The effect of acupuncture on oestrogen receptors in rats with benign prostatic hyperplasia.

  2023cites this paper
• Role of Phytotherapy in the Management of BPH: A Summary of the Literature

  2023cites this paper
• A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia

  2023cites this paper
• METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner

  2022cites this paper
• The African cherry: A review of the botany, traditional uses, phytochemistry, and biological activities of Prunus africana (Hook.f.) Kalkman.

  2022cites this paper
• Decoding ceRNA regulatory network and autophagy-related genes in benign prostatic hyperplasia.

  2022cites this paper
• Modulation of Cytoskeleton, Protein Trafficking, and Signaling Pathways by Metabolites from Cucurbitaceae, Ericaceae, and Rosaceae Plant Families

  2022cites this paper
• Effect of Beclin-1 gene silencing on autophagy and apoptosis of the prostatic hyperplasia epithelial cells

  2022cites this paper
• Piperazine-Derived α1D/1A Antagonist 1- Benzyl-N- (3-(4- (2-Methoxyphenyl) Piperazine-1-yl) Propyl) -1H- Indole-2- Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking

  2021cites this paper
• Treatment of Benign Prostatic Hyperplasia by Natural Drugs

  2021cites this paper
• Effects of Saussurea costus on apoptosis imbalance and inflammation in benign prostatic hyperplasia.

  2021cites this paper
• Pygeum africanum (Bitter Almond)

  2020cites this paper
• Review of the experience and evidence of Pygeum africanum in urological practice

  2020cites this paper
• Review of the experience and evidence of Pygeum africanum in urological practice.

  2020cites this paper
• Hyperplasie bénigne de la prostate et incontinence urinaire

  2020cites this paper
• Self-Assessed Benefits of a Prostate Health Formulation on Nocturia in Healthy Males With Mild Lower Urinary Tract Symptoms: An Open Label Study

  2020cites this paper
• [Benign prostatic hyperplasia and urinary incontinence].

  2020cites this paper
• Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet

  2019cites this paper
• Potential Therapeutic Effects of Underground Parts of Kalanchoe gastonis-bonnieri on Benign Prostatic Hyperplasia

  2019cites this paper
• Kidney, skeletal muscle and myocardium as potential target sites of Pygeum africanum toxicity in Wistar rats.

  2019cites this paper
• Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway

  2019cites this paper
• Roles of autophagy in androgen-induced benign prostatic hyperplasia in castrated rats

  2018cites this paper
• Effective Compounds of prevention and treatment of Prostate disorders

  2017cites this paper
• Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia

  2016influential citation
• Cytotoxicity of 91 Kenyan indigenous medicinal plants towards human CCRF-CEM leukemia cells.

  2016cites this paper
• PHYTOTHERAPEUTIC APPROACH TO BENIGN PROSTATIC HYPERPLASIA TREATMENT BY PUMPKIN SEED (CUCURBITA PEPO L., CUCURBITACEAE)

  2016cites this paper
• Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells.

  2015cites this paper
• Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat

  2015cites this paper
• What do we know about phytotherapy of benign prostatic hyperplasia?

  2015cites this paper
• Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat

  2015cites this paper
• An overview of phytotherapeutic approaches for the treatment of benign prostatic hyperplasia.

  2014cites this paper
• The pharmacological effects of natural products and herbs in benign prostatic hyperplasia

  2014cites this paper
• Les médicaments de l'urètre

  2013cites this paper
• Potential efficacy of some african plants in benign prostatic hyperplasia and prostate cancer.

  2013cites this paper
• A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.

  2013cites this paper
• Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma

  2013cites this paper
• [Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma].

  2013cites this paper
• [Drug therapy of urethral diseases].

  2013cites this paper
• Fraction of Macroporous Resin from Smilax china L. Inhibits Testosterone Propionate–Induced Prostatic Hyperplasia in Castrated Rats

  2012cites this paper
• Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures.

  2012cites this paper
• Bioactive constituents in Prunus africana: geographical variation throughout Africa and associations with environmental and genetic parameters.

  2012cites this paper
• Herbální přípravky používané při léčbě příznaků benigní hyperplazie prostaty

  2012cites this paper
• Droghe contenenti lipidi

  2011cites this paper
• Effects of a nanocomposite containing Orbignya speciosa lipophilic extract on Benign Prostatic Hyperplasia.

  2011cites this paper
• Normal prostate‐derived stromal cells stimulate prostate cancer development

  2011cites this paper
• The effect of β irradiation on apoptosis in human hyperplastic prostatic tissues

  2011cites this paper